Back to search

Article

Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics

2023-09-28

Abstract excerpt

Elderly patients with AML ineligible for induction have dismal prognosis; hence disease stabilization is a primary treatment goal. This case of a 74-year-old patient with secondary AML receiving the combination of decitabine and ATRA (within the DECIDER trial, NCT00867672) demonstrates an above-average survival. The therapy administered over 52 cycles led to complete molecular and hematological remission and resul...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
23407700-04bf-528c-85eb-f68d79efb8d1
DOI
10.21203/rs.3.rs-3353210/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk geneticsDOI 10.21203/rs.3.rs-3353210/v1
Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine.Semantic proximity
Continued decitabine/all-trans retinoic acid treatment: extended complete remission in an elderly AML patient with multi-hit TP53 lesions and complex-monosomal karyotype.Semantic proximity
Genetic features and efficacy of decitabine-based chemotherapy in elderly patients with acute myeloid leukemia.Semantic proximity
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceSemantic proximity
Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine-based chemotherapy.Semantic proximity
ATRA Resistance in Acute Promyelocytic Leukemia: Mechanisms Unveiled, Therapies ReimaginedSemantic proximity
Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia - identification of responders by gene expression profiling of pretreatment leukemic cells.Semantic proximity
Clinical Results of Hypomethylating Agents in AML TreatmentSemantic proximity
The antileukemic activity of decitabine upon PML/RARA-negative AML blasts is supported by all-trans retinoic acid: in vitro and in vivo evidence for cooperationSemantic proximity
Unlocking the potential of retinoic acid in anticancer therapySemantic proximity
Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study GroupSemantic proximity
Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.Semantic proximity
Select a neighboring publication to make it the new centre.